首页 > 市场调查报告书 > 製药

感染疾病

抗菌药物抗药性监测市场规模、份额及成长分析（按组件、技术、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1914058

抗菌药物抗药性监测市场规模、份额及成长分析（按组件、技术、最终用户和地区划分）－2026-2033年产业预测

Antimicrobial Resistance Surveillance Market Size, Share, and Growth Analysis, By Component (Software, Hardware), By Technology (Phenotypic Methods, Genotypic Methods), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月30日 | 出版商:

SkyQuest | 英文 191 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球抗生素抗药性监测市场规模预计在 2024 年达到 62.3 亿美元，从 2025 年的 65.8 亿美元成长到 2033 年的 101.7 亿美元，在预测期（2026-2033 年）内复合年增长率为 5.6%。

抗菌素抗药性日益普遍的构成日益严重的全球健康威胁，促使各国政府、卫生组织和政府间联盟加强监测系统。抗药性感染疾病的增加推动了对即时数据收集、病原体追踪和抗药性模式分析的需求，凸显了先进抗菌素抗药性监测解决方案的必要性。公共卫生应对能力的提升和对感染控制的日益重视正在显着推动市场扩张。同时，监管标准和国际倡议也在推动监测能力的增强。许多国家正在投资检查室基础设施、整合数据平台和即时数据报告工具，以加强这些监测系统。医疗服务提供者正在利用这些进步来实施感染控制通讯协定，从而促进抗菌药物管理并减少医疗相关感染，为市场的持续成长奠定基础。

全球抗菌素抗药性监测市场驱动因素

抗药性感染疾病的日益普遍已成为全球重大的公共卫生问题。抗药性的快速上升促使各国政府和卫生组织开发先进的监测系统，以便即时检测抗药性模式并迅速做出反应。国家和地方政府已认识到加强抗生素抗药性监测的迫切性，并为此共同努力，以防止感染传播、最大限度地减少治疗失败，并协助制定国家卫生政策。这种日益增强的意识和对有效监测解决方案的需求是推动全球抗生素抗药性监测市场成长的关键因素。

限制全球抗菌素抗药性监测市场的因素

建立有效的抗菌素抗药性监测系统面临许多挑战，其中之一是实验室基础设施、数据整合技术以及专业人员培训所需的大量资金投入。在资源往往有限的低收入国家，这项挑战尤其突出。此外，利用基因组学方法分析监测数据成本高昂，进一步限制了全球抗菌素抗药性监测倡议的推广和实施。这些资金和营运方面的障碍阻碍了进展，限制了市场的潜在成长，凸显了进行有针对性的投资和国际合作以加强全球监测能力的必要性。

全球抗菌素抗药性监测市场趋势

全球抗菌药物抗药性监测市场正经历一个显着趋势：人工智慧 (AI) 与基因组调查方法的融合。先进的人工智慧平台与全基因测序和生物资讯学的融合正在革新抗药性基因的检测方式，从而能够更准确、更快速地识别抗菌药物威胁。这种技术协同作用不仅增强了医疗系统在疫情爆发期间发布即时警报的能力，而且显着提升了预测建模能力，最终促成更有效的干预策略。这显着提高了全球医疗系统的监测能力，并促进了针对抗菌药物抗药性的主动应对措施。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

bioMerieux SA（France）
Thermo Fisher Scientific Inc.（USA）
BD（USA）
Roche Diagnostics（Switzerland）
OpGen Inc.（USA）
Luminex Corporation（USA）
Accelerate Diagnostics Inc.（USA）
Merck KGaA（Germany）
Danaher Corporation（USA）
Bruker Corporation（USA）
QuantuMDx Group Ltd.（United Kingdom）
ArcBio LLC（USA）
Bugworks Research Inc.（India）

结论与建议

简介目录

Product Code: SQMIG35G2347

Global Antimicrobial Resistance Surveillance Market size was valued at USD 6.23 Billion in 2024 and is poised to grow from USD 6.58 Billion in 2025 to USD 10.17 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The escalating prevalence of antimicrobial resistance poses significant global health threats, prompting a coalition of governments, health organizations, and intergovernmental bodies to enhance surveillance systems. There is an increasing demand for real-time data collection, pathogen tracking, and resistance pattern analysis as drug-resistant infections rise, highlighting the necessity for sophisticated antimicrobial resistance surveillance solutions. This heightened emphasis on public health readiness and infection management is substantially propelling market expansion. In tandem, regulatory standards and international initiatives are driving the enhancement of surveillance capabilities. Many nations are investing in laboratory infrastructure, integrated data platforms, and immediate data reporting tools to strengthen these surveillances. Healthcare providers are leveraging these advancements to align with infection control protocols, thereby promoting antimicrobial stewardship and reducing healthcare-related infections, paving the way for sustained market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antimicrobial Resistance Surveillance market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Antimicrobial Resistance Surveillance Market Segments Analysis

Global Antimicrobial Resistance Surveillance Market is segmented by Component, Technology, End User and region. Based on Component, the market is segmented into Software, Hardware and Services. Based on Technology, the market is segmented into Phenotypic Methods, Genotypic Methods and Bioinformatics Solutions. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes and Public Health Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Antimicrobial Resistance Surveillance Market

The escalating prevalence of drug-resistant infections has emerged as a serious global public health concern. The surge in resistance rates has prompted federal and health organizations to develop sophisticated surveillance systems capable of detecting resistance patterns in real-time, facilitating prompt response measures. As both national and local governments recognize the critical need for enhanced antimicrobial resistance surveillance, there is a concerted effort to avert outbreaks, minimize treatment failures, and support the formation of national health policies. This heightened awareness and demand for effective monitoring solutions are key factors driving the growth of the global antimicrobial resistance surveillance market.

Restraints in the Global Antimicrobial Resistance Surveillance Market

The development of an effective antimicrobial resistance surveillance system is hindered by substantial financial requirements for laboratory infrastructure, data integration technologies, and the training of skilled personnel. This challenge is particularly pronounced in lower-income nations, where resources are often limited. Moreover, the expensive nature of analyzing surveillance data through genomic methods further restricts the reach and implementation of global antimicrobial resistance surveillance initiatives. These financial and operational barriers collectively impede progress and limit the potential growth of the market, highlighting the need for targeted investments and international collaboration to enhance surveillance capabilities worldwide.

Market Trends of the Global Antimicrobial Resistance Surveillance Market

The Global Antimicrobial Resistance Surveillance market is experiencing a notable trend of integrating artificial intelligence (AI) with genomic surveillance methodologies. This convergence of advanced AI platforms with whole-genome sequencing and bioinformatics is revolutionizing the detection of resistance genes, thus facilitating more precise and timely identification of antimicrobial threats. This technological synergy not only enhances the ability of healthcare systems to provide real-time alerts during outbreaks but also significantly strengthens predictive modeling, ultimately leading to more effective intervention strategies. As a result, the surveillance capabilities of healthcare systems globally are being substantially improved, fostering proactive measures against antimicrobial resistance.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Antimicrobial Resistance Surveillance Market Size by Component & CAGR (2026-2033)

Market Overview
Software
Hardware
Services

Global Antimicrobial Resistance Surveillance Market Size by Technology & CAGR (2026-2033)

Market Overview
Phenotypic Methods
Genotypic Methods
Bioinformatics Solutions

Global Antimicrobial Resistance Surveillance Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals and Clinics
Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Public Health Agencies

Global Antimicrobial Resistance Surveillance Market Size & CAGR (2026-2033)

North America (Component, Technology, End User)
- US
- Canada
Europe (Component, Technology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Component, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Component, Technology, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Component, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OpGen Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accelerate Diagnostics Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuantuMDx Group Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ArcBio LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bugworks Research Inc. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments